HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1.

Abstract
Cultured human epithelial cells infected with an ICP27 deletion strain of herpes simplex virus type 1 (HSV-1) show characteristic features of apoptotic cells including cell shrinkage, nuclear condensation, and DNA fragmentation. These cells do not show such apoptotic features when infected with a wild-type virus unless the infections are performed in the presence of a protein synthesis inhibitor. Thus, both types of virus induce apoptosis, but the ICP27-null virus is unable to prevent this process from killing the cells. In this report, we show that this ICP27-deficient virus induced apoptosis in human HEp-2 cells through a pathway which involved the activation of caspase-3 and the processing of the death substrates DNA fragmentation factor and poly(ADP-ribose) polymerase. The induction of apoptosis by wild-type HSV-1 occurred prior to 6 h postinfection (hpi), and de novo viral protein synthesis was not required to induce the process. The ability of the virus to inhibit apoptosis was shown to be effective between 3 to 6 hpi. Wild-type HSV-1 infection was also able to block the apoptosis induced in cells by the addition of cycloheximide, staurosporine, and sorbitol. While U(S)3- and ICP22-deficient viruses showed a partial prevention of apoptosis, deletion of either the U(L)13 or vhs gene products did not affect the ability of HSV-1 to prevent apoptosis in infected cells. Finally, we demonstrate that in UV-inactivated viruses, viral binding and entry were not sufficient to induce apoptosis. Taken together, these results suggest that either gene expression or another RNA metabolic event likely plays a role in the induction of apoptosis in HSV-1-infected human cells.
AuthorsM Aubert, J O'Toole, J A Blaho
JournalJournal of virology (J Virol) Vol. 73 Issue 12 Pg. 10359-70 (Dec 1999) ISSN: 0022-538X [Print] United States
PMID10559354 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Caspase Inhibitors
  • Enzyme Inhibitors
  • ICP22 protein, human herpesvirus 1
  • ICP27 protein, human herpesvirus 1
  • Immediate-Early Proteins
  • Viral Proteins
  • Viral Regulatory and Accessory Proteins
  • herpes simplex virus, type 1 protein ICP4
  • virion host shutoff protein, Simplexvirus
  • EUS1 protein, Equine herpesvirus 1
  • Sorbitol
  • Protein Kinases
  • UL13 protein, Simplexvirus
  • Protein Serine-Threonine Kinases
  • US3 protein, Human herpesvirus 1
  • Ribonucleases
  • CASP3 protein, human
  • Caspase 3
  • Staurosporine
Topics
  • Animals
  • Apoptosis
  • Caspase 3
  • Caspase Inhibitors
  • Chlorocebus aethiops
  • Enzyme Inhibitors (pharmacology)
  • Gene Deletion
  • Herpesvirus 1, Human (metabolism, physiology)
  • Humans
  • Immediate-Early Proteins (biosynthesis, genetics, physiology)
  • Protein Kinases (genetics)
  • Protein Serine-Threonine Kinases (genetics)
  • Ribonucleases
  • Sorbitol
  • Staurosporine (pharmacology)
  • Time Factors
  • Tumor Cells, Cultured
  • Vero Cells
  • Viral Proteins (genetics)
  • Viral Regulatory and Accessory Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: